Recall of 13 Lots of Ketorolac Tromethamine Injection, USP

Company Announcement Date: April 20, 2020

FDA Publish Date: April 20, 2020


Product Type: Drugs Reason for Announcement: Presence of Particulate Matter Company Name: Fresenius Kabi USA, LLC

Brand Name: Fresenius Kabi Product Description: Ketorolac Tromethamine Injection, USP, 30 mg/mL, and Ketorolac Tromethamine Injection, USP, 60 mg/2 mL


MORE INFORMATION

© 2020 The Consumer News™

7800 Whipple Ave. NW

North Canton, Ohio 44720

  • Facebook